Fly News Breaks for March 3, 2015
IG
Mar 3, 2015 | 08:21 EDT
After IGI Laboratories reported stronger than expected results but provided lower than expected fiscal 2015 revenue guidance, Oppenheimer thinks the company reported strong top-line results, while its guidance is conservative. The firm continues to be upbeat about the outlook for the company's pipeline in 2016. It keeps a $12 price target and Outperform rating on the shares.
News For IG From the Last 2 Days
There are no results for your query IG